CADX: Cadence Pharmaceuticals, Inc. Twitter

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Friday, May 3, 6:52 AM Cadence (CADX): Q1 EPS of -$0.02 beats by $0.13. Revenue of $23.6M beats by $3.75M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, March 7, 11:57 AM Cadence Pharmaceutical (CADX +2%) moves up after beating Q4 estimates across the board. Total revenue rose over 180% Y/Y, driven by higher licensing revenue driven by it's data license agreement with Terumo Corporation. Terumo intends to seek regulatory approval in Japan for the same intravenous formulation of acetaminophen as CADX's Ofirmev. 1 Comment [Healthcare, On the Move, Earnings]
Thursday, March 7, 7:41 AM Cadence Pharmaceuticals (CADX): Q4 EPS of -$0.15 beats by $0.01. Revenue of $17.2M beats by $0.5M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Friday, December 14, 2012, 5:39 PM After-hours top gainers, as of 5:15 p.m.: ETH +10%. TVL +7%. AVG +5%. ARQL +5%. EZPW +4%.
After-hours top losers: CADX -6%. AVNR -5%. ITG -5%. BEBE -5%. ISIS -4%. 1 Comment [On the Move]
Wednesday, December 12, 2012, 12:47 PM As a condition of Medicines Company's (MDCO +1.9%) acquisition of Incline Therapeutics, Cadence Pharmaceuticals (CADX +4.9%) has agreed to terminate its exclusive option to acquire Incline. Upon MDCO's closing of the deal, CADX will receive around $13M in termination fees and roughly $1.5M for its Incline stake as well as a pro-rated share of future milestone payments. Comment! [Healthcare, On the Move, M&A]
Wednesday, November 28, 2012, 10:01 AM Cadence Pharmaceuticals (CADX +3.4%) and Perrigo (PRGO -1.3%) settle a lawsuit over Cadence's Ofirmev injection for reducing fever and pain. Under the deal, Perrigo has the first right of refusal to market any generic version of Ofirmev in the U.S. should Cadence decide to authorize such a version. Perrigo will also be allowed to launch a copycat drug in 2020. (PR) Comment! [Healthcare]
Tuesday, February 7, 2012, 1:54 PM Cadence Pharmaceuticals (CADX +0.1%) voluntarily recalls some of its Ofirmev pain reliever injection vials after an unidentified particle was found in one of the lot's vials during routine stability testing. Comment! [Healthcare]
Tuesday, November 15, 2011, 11:34 AM Cadence Pharmaceuticals (CADX -4.5%) trades down after pricing its 19M share offering at $3.75 per share, a 5.5% discount to Monday's closing price. Comment! [Healthcare, On the Move]
Tuesday, November 15, 2011, 9:05 AM Premarket gainers: CIM +7%. MX +7%. DKS +6%. RVBD +3%.
Losers: GERN -20%. HAFC -15%. LDK -8%. CADX -8%. PVR -6%. NBG -5%. FRO -5%. ING -5%. ATVI -5%. URBN -4%. KOG -4%. CS -4%. TTWO -4%. LOGI -3%. MT -3%. Comment! [On the Move]
Monday, November 14, 2011, 10:50 AM Cadence Pharmaceuticals (CADX -15.8%) takes a hit after announcing plans for a $75M secondary stock offering. The company plans to use the majority of the funds for research and development of its injectable acetaminophen drug Ofirmev. Comment! [Healthcare, On the Move]
Monday, November 14, 2011, 10:05 AM Cadence Pharmaceuticals (CADX) trades 13.1% lower after announcing a plan to sell $75M of common stock on a market cap sitting south of $300M. Undeterred by the firm's new public offering of shares, Colins Stewart initiates coverage with a Buy rating and a lofty $7 price target. 1 Comment [On the Move, Healthcare]
Monday, April 19, 2010, 10:22 AM Shares of Cadence Pharmaceuticals (CADX +12.0%) jump on news that the company will resubmit its market application for U.S. approval of its acetaminophen intravenous formulation within 30 days. (PR) Comment!
Thursday, February 11, 2010, 9:00 AM Premarket gainers: AZC +24%. LF +18%. SOL +12%. AYE +11%. JASO +8%. ATVI +6%. CPA +4%.
Losers: ELON -15%. SWIR -15%. CADX -13%. HOS -12%. BSX -8%. ALU -8%. FE -4%. Comment!
Friday, November 13, 2009, 9:00 AM Premarket gainers: TSTC +31%. RINO +18%. LXRX +17%. ANF +7%. MDSO +7%. JCP +5%. PLA +4%.
Losers: LBTYA -9%. LKFN -7%. CADX -6%. TCLP -5%. JWN -4%. Comment!
Friday, March 13, 2009, 6:39 PM Healthcare was the strongest sector Friday, up 2.44% overall. Biggest gainers: CADX +19.2%; DNDN +18.2%; NPSP+17.5%; EVVV +13.9%; MYL +12.8%; MRK +12.7%. The only double-digit loser on the day: PGNX -16.1%. Comment!

CADX Cadence Pharmaceuticals, Inc.

CADX

Cadence Pharmaceuticals, Inc.